ArticleAnnals of hematology2024

Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis.

Alexander Denk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.